Phase 0 Trial of Presurgical Cholesterol-lowering on Prostate Cancer Cell Growth
Description: 
To determine if cholesterol-lowering therapy with ezetimibe and simvastatin will decrease the growth of Gleason grade 3 prostate cancer.
Study Number: 

I 278515

Phase: 
0
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT02534376

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.